STOCK TITAN

Henry Schein Stock Price, News & Analysis

HSIC NASDAQ

Company Description

Overview

Henry Schein (HSIC) is a global powerhouse in the provision of health care products and services, servicing office-based dental, medical, and animal health practices. As a company with expansive reach in the health care distribution and medical supply sectors, Henry Schein leverages a centralized, automated distribution network to offer an extensive inventory that includes thousands of branded items alongside its own private-label products. With a focus on operational efficiency and quality care, Henry Schein remains a trusted partner for practitioners, dental laboratories, government, and institutional health care clinics worldwide.

Comprehensive Product and Service Portfolio

At its core, Henry Schein delivers more than just products; it provides a suite of integrated solutions designed to support and streamline clinical operations. The company’s portfolio spans a wide array of product categories including dental supplies, medical instruments, and animal health products. In addition, Henry Schein supports its customers with value-added services, practice management solutions, and innovative technologies that assist in optimizing operational success and enhancing clinical outcomes.

Technology Integration and Centralized Distribution

Central to Henry Schein's strategy is its robust, technology-driven approach which employs a centralized distribution network. This system not only ensures rapid and reliable delivery of essential medical supplies but also supports the high-volume inventory management necessary to meet the dynamic demands of global health care providers. By integrating advanced technology, the company facilitates streamlined order fulfillment, efficient supply chain management, and improved access to cutting-edge practice solutions.

Market Position and Competitive Landscape

Henry Schein holds a significant market position as one of the foremost providers in its industry. Its extensive global network, underscored by affiliations with major financial indexes and a comprehensive supplier ecosystem, positions it uniquely among its competitors. The company's scale, combined with its operational expertise, allows it to address complex logistical challenges and cater to diverse customer needs across various care settings. This makes Henry Schein a pivotal player in the competitive landscape of health care services and products.

Strategic Acquisitions and Innovation

The company’s portfolio has been further enhanced through strategic acquisitions. An example is its integration of specialized providers, such as the recent acquisition of a company with expertise in Continuous Glucose Monitors (CGM), which complements its broad product offering. Such moves reflect Henry Schein's commitment to innovation and comprehensive care solutions, strengthening its ability to serve diverse practice areas with tailored, technologically advanced products.

Operational Excellence and Value Proposition

Henry Schein’s primary value proposition lies in its dual commitment to quality and efficiency. The company excels in offering a seamless blend of extensive product inventory and integrated service solutions, ensuring that healthcare professionals can focus on delivering superior patient care. The reliance on an efficient distribution network, coupled with ongoing investment in technology, underscores the company’s role as a critical enabler for operational excellence within the health care sector.

Expertise and Industry Knowledge

With decades of experience, Henry Schein has cultivated deep expertise in the intricacies of health care supply chains. Its ability to manage a vast network and deliver specialized products across multiple practice areas is a testament to its operational sophistication. The company’s approach is rooted in a profound understanding of the challenges faced by healthcare providers, and its service model is crafted to address these challenges head on with credible, reliable, and expertly managed solutions.

In Summary

Henry Schein remains a formidable force in the health care product and service sector by continuously evolving to meet the needs of a diverse client base. Its strategic integration of technology, commitment to quality, and expansive product portfolio not only support clinical practices but also enhance overall customer experience. For investors and market analysts, Henry Schein stands out as a company with a solid operational foundation, leveraging a synergy of comprehensive solutions, strategic acquisitions, and a technology-first approach to maintain its influential market presence.

Stock Performance

$—
0.00%
0.00
Last updated:
-9.53 %
Performance 1 year
$7.8B
Market Cap
122.5M
Shares outstanding

SEC Filings

No SEC filings available for Henry Schein.

Financial Highlights

$12,673,000,000
Revenue (TTM)
$398,000,000
Net Income (TTM)
$3.05
Diluted EPS (TTM)
$848,000,000
Operating Cash Flow
3.14%
Net Profit Margin
4.90%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $66.23 as of April 24, 2025.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 7.8B.

What is the revenue (TTM) of Henry Schein (HSIC) stock?

The trailing twelve months (TTM) revenue of Henry Schein (HSIC) is $12,673,000,000.

What is the net income of Henry Schein (HSIC)?

The trailing twelve months (TTM) net income of Henry Schein (HSIC) is $398,000,000.

What is the earnings per share (EPS) of Henry Schein (HSIC)?

The diluted earnings per share (EPS) of Henry Schein (HSIC) is $3.05 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Henry Schein (HSIC)?

The operating cash flow of Henry Schein (HSIC) is $848,000,000.

What is the profit margin of Henry Schein (HSIC)?

The net profit margin of Henry Schein (HSIC) is 3.14%.

What is the operating margin of Henry Schein (HSIC)?

The operating profit margin of Henry Schein (HSIC) is 4.90%.

What is the gross margin of Henry Schein (HSIC)?

The gross profit margin of Henry Schein (HSIC) is 31.69%.

What is the current ratio of Henry Schein (HSIC)?

The current ratio of Henry Schein (HSIC) is 1.42, indicating the company's ability to pay short-term obligations.

What is the gross profit of Henry Schein (HSIC)?

The gross profit of Henry Schein (HSIC) is $4,016,000,000 on a trailing twelve months (TTM) basis.

What is the operating income of Henry Schein (HSIC)?

The operating income of Henry Schein (HSIC) is $621,000,000.

What is the primary business of Henry Schein?

Henry Schein provides health care products and services primarily to office-based dental, medical, and animal health practitioners. It focuses on a wide range of products, including branded and private-label items, and offers comprehensive solutions to improve practice efficiency.

How does Henry Schein support its customers?

The company supports its customers through a centralized distribution network, innovative technology solutions, and value-added services that enable more efficient practice management and improved clinical outcomes.

What distinguishes Henry Schein in the competitive healthcare market?

Henry Schein is distinguished by its extensive product portfolio, robust technological infrastructure, and its ability to serve a diverse range of healthcare providers. Its strategic acquisitions further reinforce its integrated service model and market reach.

How does Henry Schein generate its revenue?

Revenue is generated through direct sales of a comprehensive range of healthcare products, including specialty medical supplies, along with value‐added services and technological solutions that support operational efficiency in healthcare practices.

What role does technology play in the company’s operations?

Technology is central to Henry Schein's operations, enhancing its centralized and automated distribution network. This approach facilitates efficient inventory management, streamlined order fulfillment, and effective customer service across global healthcare markets.

How are strategic acquisitions integrated into Henry Schein's business model?

The company leverages strategic acquisitions to enhance its product portfolio and service offerings. Such integrations, as seen with the acquisition of a specialized supplier in continuous glucose monitoring, allow Henry Schein to broaden its technological and operational capabilities.

Who are the main customers of Henry Schein?

Henry Schein serves a broad customer base including office-based practitioners in dental, medical, and animal health sectors, as well as dental laboratories, government and institutional clinics, and alternate care sites.

How does Henry Schein ensure quality and operational efficiency?

By employing a centralized and automated distribution network coupled with state-of-the-art technology solutions, Henry Schein ensures efficient supply chain management and high-quality service delivery, which are critical to enhancing the operational success of healthcare practices.